Erlotinib Tablet is indicated for:
- The first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor(EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.
- The maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer, whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.
- The treatment of patients with locally advanced or metastatic non- small cell lung cancer after failure of at least one prior chemotherapy regimen.
Siddha Global is Supplier,Exporter ,Wholesaler for Erlotinib Tablet 100mg & 150 mg in India.
We even offer contract manufacturing services from WHO GMP approved factories.
ERLOTINIB TABLET 100MG & 150 MG